Abstract
A number of mouse hepatitis viruses, including MHV-A59, MHV-3, and JHM, have been used as in vivo models of neurotropic viral infections (Hirano et al., 1980; Knobler et al., 1981; Lampert et al., 1973; Le Prevost et al., 1975). The majority of experiments with these agents have involved mice as the host, a system which may be complicated by the viscerotropism of some of these coronaviruses. Previous work in our laboratory (Sorensen et al., 1980, 1982) and by others (Nagashima et al., 1978, 1979; Hirano et al., 1980) demonstrated that rats injected intracerebrally (IC) with JHM virus (JHMV) offer a challenging model for studies of neurotropic agents interacting with the central nervous system (CNS). The presence of anti-coronavirus antibodies in a high proportion of the human population (MacNaughton, 1982) give these models added relevance in regard to enquiries into the viral etiology of human diseases of the central nervous system (CNS), among them multiple sclerosis.
Chapter PDF
Similar content being viewed by others
Keywords
- Mixed Culture
- Demyelinating Disease
- Central Nervous System Tissue
- Mouse Hepatitis Virus
- cDNA Hybridization
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Abney, E.R., Bartlett, P.P., and Raff, M.C. 1981. Astrocytes, ependymal cells, and oligodendrocytes develop on schedule in dissociated cell cultures of embryonic rat brain Developmental Biol. 83:301–310.
Bailey, T.O., Pappenheimer, A.M., Cheever, F.S., and Daniels, J.B. 1949. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. II. Pathology. J. Exp. Med. 90:195–231.
Brahic, M., and Haase, A.T. 1978. Detection of viral sequences of low reiteration frequency by in situ hybridization Proc. Natl. Acad. Sci. U.S.A. 55:6125–6129.
Cheley, S., Anderson, R., Cupples, M.J., Chan, E.C.M.L., and Morris, V.L. 1981a. Intracellular murine hepatitis virus-specific RNA’s contain common sequences. Virology 112:596–604.
Cheley, S., Morris, V.L., Cupples, M.J., and Anderson, R. 1981b. RNA and polypeptides homology among murine coronaviruses. Virology 115:310–321.
Fleming, J.O., Ting, J.Y.P., Stohlman, S.A., and Weiner, L.P. 1983. Improvements in obtaining and characterizing mouse cerebrospinal fluid. Application to mouse hepatitis virus-induced encephalomyelitis. J. Neuroimmunol. 4:129–140.
Hirano, N., Goto, N., Ogawa, T., Ono, K., Murakawi, T., and Fujiwara, K. 1980. Hydrocephalus in suckling rats infected intracerebrally with mouse hepatitis virus, MHV-A59. Microbiol. Immunol. 24:825–834.
Knobler, R.L., Haspel, M.V., and Oldstone, M.B.A. 1981. Mouse hepatitis virus type 4 (JHM strdin)-induced fatal central nervous system disease. I. Genetic control and the murine neuron as the susceptible site of disease. J. Exp. Med. 153:832–843.
Lampert, P.W., Sims, J.K., and Kiazeff, A.J., 1973. Mechanism of demyelination of JHM virus encephalomyelitis, Electron microscopic studies. Acta Neuropathol. 24:76–85.
Le Prevost, C., Virelizier, J.L., and Dupuy, J.M. 1975. Immunopathology of mouse hepatitis virus type 3. III. Clinical and virologic observations of a persistent viral infection. J. Immunol. 115:640–643.
Lucas, A., Coulter, M., Anderson, R., Dales, S., and Flintoff, W. 1978. In vivo and in vitro models of demyelinating diseases. II. Persistence and host-regulated themosensitivity in cells of neural derivation infected with mouse hepatitis and measles viruses. Virology 88:325–337.
Lucas, A., Flintoff, W., Anderson, R., Percy, D., Coulter, M., and Dales, S. 1977. In vivo and in vitro models of demyelinating diseases: Tropism of the JHM strain of murine hepatitis virus for cells of glial origin. Cell 12:553–560.
MacNaughton, M.R. 1982. Occurrence and frequency of coronavirus infections in humans as determined by enzyme-linked immunosorbent assay. Infect. Immun 38:419–423.
Martin, J.R., Goudswaard, J., Palsson, P.A., Georgsson, G., Petursson, G., Klein, J., and Nathanson, N. 1982. Cerebrospinal fluid immunoglobulins in sheep with Visna, a slow virus infection of the central nervous system. J. Neuroimmunol. 3:139–148.
McCarthy, K.D., and de Vellis, J. 1978. Alpha-adrenergic receptor modulation of beta-adrenergic, adenosine and protaglandin E1 increased adenosine 3′:5′-cyclic monophosphate levels in primary cultures of glia. J. Cyclic Nuc. Res. 4:15–26.
Nagashima, K., Wege, H., Meyermann, R., and ter Meulen, V. 1978. Coronavirus induced subacute demyelinating encephalomyelitis in rats: a morphological analysis. Acta Neuropathol. 44:63–70.
Nagashima, K., Wege, H., Meyermann, R., and ter Meulen, V. 1979. Demyelinating encephalomyelitis induced by long-term coronavirus infection in rats, A preliminary report. Acta Neuropathol. 45:205–213.
Robb, J.A., and Bond, C.W. 1979. Coronaviridae. Comp. Virol. 14:193–247.
Sehliep, G., and Felgenhauer, K. 1978. Serum-CSF protein gradients, the blood-CSF barrier and the local immune response. J. Neurol. 218:77–96.
Sorensen, O., Dugre, R., Percy, D., and Dales, S. 1982. In vivoand in vitro models of demyelinating disease: Endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice. Infect. Immun. 37:1248–1260.
Sorensen, O., Percy, D., and Dales, S. 1980. In vivo and in vitromodels of demyelinating disease. III. JHM virus infection of rats. Arch. Neurol. 37:478–484.
Stroop, W.G., Baringer, J.R., and Brahic, M. 1981. Detection of Theiler’s virus RNA in mouse central nervous system by in situ hybridization. Lab. Invest. 45:504–509.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Sorensen, O. et al. (1984). In Vivo and In Vitro Models of Demyelinating Diseases — VIII: Genetic, Immunologic and Cellular Influences on JHM Virus Infection of Rats. In: Rottier, P.J.M., van der Zeijst, B.A.M., Spaan, W.J.M., Horzinek, M.C. (eds) Molecular Biology and Pathogenesis of Coronaviruses. Advances in Experimental Medicine and Biology, vol 173. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9373-7_29
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9373-7_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9375-1
Online ISBN: 978-1-4615-9373-7
eBook Packages: Springer Book Archive